Predicting hepatocellular carcinoma through cross-talk genes identified by risk pathways

Area of Science:

• Oncology
• Bioinformatics
• Genomics

Background:

• Hepatocellular carcinoma (HCC) is a prevalent liver cancer with high mortality.
• Existing diagnostic and prognostic tools for HCC require improvement.
• Novel molecular markers are crucial for precise HCC management.

Purpose of the Study:

• To identify reliable molecular markers for hepatocellular carcinoma (HCC) diagnosis and prognosis.
• To develop a gene signature for distinguishing HCC patients from healthy individuals.
• To explore the potential of identified genes as biomarkers for HCC evaluation.

Main Methods:

• Integrated HCC transcriptome data with protein interaction networks and pathway analysis.
• Constructed a HCC-specific gene network and identified pivotal genes.
• Developed a 45-gene signature based on pathway crosstalk analysis.

Main Results:

• A 45-gene signature was identified, capable of accurately distinguishing HCC patients from normal individuals.
• The signature also revealed prognostic information for HCC patients.
• Among the 45 genes, 15 exhibited dysregulated expression, with some previously linked to HCC and other cancers.

Conclusions:

• The identified 45-gene signature holds potential as valuable molecular markers for HCC diagnosis and evaluation.
• This signature could aid in improving the management and understanding of hepatocellular carcinoma.
• Further validation is warranted to establish the clinical utility of this HCC gene signature.